(FP-TH-02.5) A plain language summary of the association between joint health and patient reported quality of life outcomes using data from the efanesoctocog alfa Phase 3 clinical trial in adults and adolescents with severe haemophilia A

Presenting Author(s)

• 

  Christoph Königs, MD, PhD

  Head Clinical and Molecular Haemostasis
  University Hospital Frankfurt, Department of Paediatrics
  Frankfurt, Germany